Muromonab-CD3 (Orthoclone OKT3)

Indications

  • Acute, Glucocorticoid-Resistant Rejection of Allogeneic Renal, Heart and Liver Transplants: FDA-approved for these indications

Pharmacology

  • Monoclonal Antibody Against T-Cell CD3 Receptor
    • OKT3 was the first monoclonal antibody to be approved for clinical use in humans

Adverse Effects


References

  • xxx